newsfilter
← Latest News
GlobeNewswire·

Keros Therapeutics Announces Final Results of Tender Offer

LEXINGTON, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ:KROS), today announced the final results of its cash tender offer (the "Tender Offer") to repurchase up to